Blueprint Medicines Corp

Blueprint Medicines Corp

BPMC

Market Cap$8.29B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Blueprint Medicines CorpBlueprint Medicines Corp-52.4--46%160.4
$141.00

Target Price by Analysts

9.9% upsideBlueprint Medicines Target Price DetailsTarget Price
$95.39

Current Fair Value

25.6% downside

Overvalued by 25.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$8.29 Billion
Enterprise Value$8.29 Billion
Dividend Yield$0 (0%)
Earnings per Share$-1.07
Beta0.83
Outstanding Shares63,600,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-52.36
PEG52.65
Price to Sales16.03
Price to Book Ratio25.65
Enterprise Value to Revenue14.75
Enterprise Value to EBIT-70.14
Enterprise Value to Net Income-54
Total Debt to Enterprise0.02
Debt to Equity0.37

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Blueprint Medicines Corp

CEO: Jeffrey Albers